Physician profile
John G Roth
NPI 1134193212
$41,788.25
in general payments reported to CMS, 2019-2025
42 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $4,411 · 2021: $1,723 · 2022: $5,304 · 2023: $1,571 · 2024: $1,501 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Food and Beverage: $5,707 · Travel and Lodging: $1,269 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Food and Beverage | $5,706.84 |
| Travel and Lodging | $1,268.54 |
| Education | $307.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19,655.93 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $8,400.30 | 2019-2025 | |
| Abbvie INC. | $2,739.90 | 2019-2025 | Skyrizi, Rinvoq |
| Davol INC. | $1,957.42 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip |
| Biofrontera INC. | $1,614.05 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Janssen Biotech, INC. | $1,187.87 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $683.86 | 2019-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $647.35 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $585.77 | 2019-2025 | |
| Lilly USA, LLC | $560.06 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $510.54 | 2019-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $431.47 | 2019-2025 | Nemluvio, Aklief, Dysport |
| Amgen INC. | $421.64 | 2019-2025 | Otezla, Otezla |
| Leo Pharma INC. | $395.92 | 2019-2025 | Adbry, Anzupgo |
| Janssen Scientific Affairs, LLC | $327.56 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.